 | Spero Therapeutics (NASDAQ:SPRO) Given Overweight Rating at Cantor Fitzgerald
www.americanbankingnews.com - March 21 at 8:50 AM |
 | Spero Therapeutics, Inc. Yearly Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
finance.yahoo.com - March 18 at 9:12 PM |
| Spero Therapeutics, Inc. Yearly Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
finance.yahoo.com - March 18 at 11:11 AM |
| Spero Therapeutics Inc (NASDAQ:SPRO) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - March 18 at 3:04 AM |
| Stifel Nicolaus Cuts Spero Therapeutics (NASDAQ:SPRO) Price Target to $21.00
www.americanbankingnews.com - March 17 at 3:21 PM |
| Spero Therapeutics (NASDAQ:SPRO) Posts Earnings Results, Misses Expectations By $0.27 EPS
www.americanbankingnews.com - March 17 at 7:14 AM |
 | Spero Therapeutics EPS misses by $0.24, misses on revenue
seekingalpha.com - March 16 at 2:55 PM |
| Spero Therapeutics, Inc. (SPRO) Reports Q4 Loss, Tops Revenue Estimates
finance.yahoo.com - March 16 at 2:55 PM |
| Spero Therapeutics Inc (NASDAQ:SPRO) Short Interest Down 42.5% in February
www.americanbankingnews.com - March 13 at 10:56 PM |
| Spero Therapeutics Inc (NASDAQ:SPRO) Expected to Announce Quarterly Sales of $3.54 Million
www.americanbankingnews.com - March 9 at 2:32 AM |
| Zacks: Analysts Expect Spero Therapeutics Inc (NASDAQ:SPRO) Will Announce Earnings of -$1.09 Per Share
www.americanbankingnews.com - March 7 at 12:54 PM |
| Spero Therapeutics Announces Closing of Rights Offering
finance.yahoo.com - March 5 at 7:59 PM |
| Earnings Preview: Spero Therapeutics, Inc. (SPRO) Q4 Earnings Expected to Decline
finance.yahoo.com - March 5 at 2:58 PM |
| Spero Therapeutics to Present at March Investor Conferences
finance.yahoo.com - February 26 at 5:46 PM |
| Spero launches rights offering
seekingalpha.com - February 11 at 2:58 PM |
| Spero Therapeutics Announces Commencement of Rights Offering
finance.yahoo.com - February 11 at 8:12 AM |
| BARDA OKs additional funding for development of Spero antibiotic
seekingalpha.com - February 5 at 2:01 PM |
| Spero Therapeutics Announces Exercise of $15.9 Million Option by BARDA for Tebipenem HBr Development
finance.yahoo.com - February 5 at 8:59 AM |
| Spero readies $30M rights offering
seekingalpha.com - January 30 at 1:41 PM |
| Spero Therapeutics Announces Proposed Rights Offering
finance.yahoo.com - January 30 at 8:41 AM |
| Introducing Spero Therapeutics (NASDAQ:SPRO), A Stock That Climbed 11% In The Last Year
finance.yahoo.com - January 16 at 12:10 PM |
| Spero Reports Preliminary Findings from Phase 1 Clinical Trial of SPR206 and Plans to Advance Program with Alliance Partners Everest Medicines and the Department of Defense
finance.yahoo.com - January 13 at 5:37 PM |
| Here is What Hedge Funds Think About Spero Therapeutics, Inc. (SPRO)
finance.yahoo.com - December 17 at 6:04 PM |
| Iterum Down as Sulopenem Antibiotic Fails in Phase III Study
finance.yahoo.com - December 12 at 12:25 PM |
| Spero Reports Preliminary Findings from Phase 1 Clinical Trial of SPR720 and Announces Plans to Advance Program into Proof-of-Concept Clinical Trial in Patients with NTM Pulmonary Disease
finance.yahoo.com - December 4 at 6:35 PM |
| Spero Therapeutics to Host Key Opinion Leader Symposium in December
finance.yahoo.com - November 26 at 9:01 AM |
| Infectiously Challenging - Spero's Exciting Progress
seekingalpha.com - November 20 at 9:03 AM |
 | BRIEF-Spero Therapeutics Announces Third Quarter 2019 Operating Results And Provides Pipeline Review
www.msn.com - November 5 at 10:24 PM |
| Spero Therapeutics Announces Third Quarter 2019 Operating Results and Provides Pipeline Review
finance.yahoo.com - November 4 at 7:51 PM |
| Spero Therapeutics, Inc. (SPRO) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 4 at 7:51 PM |
| How Many Spero Therapeutics, Inc. (NASDAQ:SPRO) Shares Do Institutions Own?
finance.yahoo.com - October 23 at 1:44 PM |
 | Spero Therapeutics Inc.
www.barrons.com - October 11 at 9:35 PM |
| Spero Therapeutics (SPRO) Presents At Cantor Healthcare Conference - Slideshow
seekingalpha.com - October 3 at 8:22 PM |
| Spero Therapeutics Announces Positive Recommendation to Continue Phase 3 Clinical Trial of SPR994 as Planned Following Independent Review Committee Analysis of SPR994 Treated Patients in Lead-in Cohort of Trial
finance.yahoo.com - October 3 at 9:40 AM |
| Spero Therapeutics Announces Presentations at IDWeek 2019
finance.yahoo.com - September 26 at 8:35 AM |
| Spero finance chief bids adieu
seekingalpha.com - September 6 at 2:19 PM |
| Spero Therapeutics, Inc. (SPRO) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 9 at 12:49 AM |
| Spero Therapeutics Announces Second Quarter 2019 Operating Results and Provides Pipeline Update
finance.yahoo.com - August 8 at 7:46 PM |
| Spero Therapeutics, Inc. (SPRO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
finance.yahoo.com - August 1 at 7:38 PM |
| Spero nabs $5.9M DoD award to support SPR206; shares up 4%
seekingalpha.com - July 16 at 6:24 PM |
| Spero Therapeutics Announces $5.9 Million Award from U.S. Department of Defense to Further Clinical Development of SPR206
finance.yahoo.com - July 16 at 9:26 AM |
| Did Changing Sentiment Drive Spero Therapeutics's (NASDAQ:SPRO) Share Price Down By 15%?
finance.yahoo.com - July 11 at 8:58 AM |
| Spero Therapeutics to Present Data for All Pipeline Programs at the ASM Microbe 2019 Conference
finance.yahoo.com - June 17 at 9:43 AM |
| Spero secures $10M capital raise
seekingalpha.com - June 13 at 1:31 PM |
| Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 10 at 9:10 AM |
| Spero Therapeutics Announces First Quarter 2019 Operating Results and Provides Pipeline Review
finance.yahoo.com - May 9 at 7:03 PM |
| Analysts Estimate Spero Therapeutics, Inc. (SPRO) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - May 2 at 7:23 PM |
| Expedia Shares Fall as Home-Rental Business Vrbo Goes Slow
finance.yahoo.com - May 2 at 7:23 PM |
| Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - May 1 at 8:57 AM |
| Spero Therapeutics Highlights SPR994 Data at the 29th European Congress of Clinical Microbiology and Infectious Diseases
finance.yahoo.com - April 8 at 10:03 AM |
